ISDS Case Map
CAFTA
US - Central America Free Trade Agreement
Passage of CAFTA is not guaranteed because of splits within the US corporate elite over the proper pace and focus of free trade.
Twelve years ago, amid heated rhetoric over job losses and heavy union pressure, the House passed the North American Free Trade Agreement with 102 Democratic votes. This month, as President Bush pushes the far less economically significant Central American Free Trade Agreement, he will be lucky to get more than 10.
Co-authored by World Bank economists Carlos Felipe Jaramillo and Daniel Lederman, provides an assessment of the agreement negotiated by Costa Rica, the Dominican Republic, El Salvador, Guatemala, Honduras and Nicaragua with the US.
The US Senate on Thursday endorsed a free trade agreement with six Latin American nations, handing a major win to President Bush.
Students, teachers and indigenous residents demonstrated Wednesday in Tegucigalpa, capital of Honduras, against the free trade agreement (FTA) between Central America and the United States.
The Bush administration and key lawmakers struck an 11th hour deal with US sugar producers to shore up congressional support for a controversial trade agreement, senators said Wednesday. A full Senate vote could come as early as Thursday on the US-Dominican Republic-Central America Free Trade Agreement (CAFTA).
An ambitious American plan for a hemispherewide trade pact, which President Bush described as a "vital link for prosperity," is mired in disputes that have led to widespread skepticism about its chances of ever materializing.
The US Senate Finance Committee won't hold an important vote on the controversial Central America Free Trade Agreement before Wednesday, delaying action on the pact by at least a day.
The lack of worker and environmental protections leads the list of concerns as CAFTA is modeled after the failed 1994 North American Free Trade Agreement, or NAFTA. At its 10-year anniversary, the verdict on NAFTA is in: It is an economic, social and environmental failure.
When George W. Bush and the U.S. pharmaceutical industry team up in Washington, you know it's bad news for U.S. consumers. Now they are taking their show on the road -- to Central America.
